Journal Home
Search for

Volume 82, Issue 1, Pages 145-148 (July 2004)


View previous. 2 of 65 View next.

Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study

Vittorio Unfer, M.D.aCorresponding Author Informationemail address, Maria Luisa Casini, Ph.D.b, Loredana Costabile, M.D.a, Marcella Mignosa, M.D.c, Sandro Gerli, M.D.c, Gian Carlo Di Renzo, M.D., Ph.D.c

Received 14 July 2003; received in revised form 12 November 2003; accepted 12 November 2003.

Abstract 

Objective

To determine the effects of 5 years of treatment with soy phytoestrogens on histological characteristics of endometrium in postmenopausal women.

Design

Randomized, double-blind, placebo-controlled study.

Setting

Centre of Perinatal and Reproductive Medicine, Department of Gynecological, Obstetrical, and Pediatric Sciences, University of Perugia, Italy.

Patient(s)

Three hundred seventy-six postmenopausal healthy women, all with intact uterus.

Intervention(s)

Women were distributed in two different groups using randomized criteria: group A (n = 179) patients received soy tablets (150 mg of isoflavones per day) for 5 years; group B (n = 197) patients received identical appearing placebo tablets for 5 years.

Main outcome measure(s)

Results of endometrial histology from biopsies obtained at baseline, 30 months, and 5 years after the beginning of the treatment.

Result(s)

Two hundred ninety-eight women completed the 5-year treatment. No cases of malignancy were detected during biopsy. Seventy percent of women undergoing treatment with soy phytoestrogens had an endometrium classified as atrophic or nonassessable versus 81% receiving placebo. The occurrence of endometrial hyperplasia was significantly higher in group A (3.37% vs. 0%).

Conclusion(s)

Long-term treatment (up to 5 years) with soy phytoestrogens was associated with an increased occurrence of endometrial hyperplasia. These findings call into question the long-term safety of phytoestrogens with regard to the endometrium.

a A.G.UN.CO., Obstetrics and Gynecology Centre, Rome, Italy

b Department of Human Physiology and Pharmacology “Vittorio Erspamer,” University “La Sapienza,” Rome, Italy

c Centre of Perinatal and Reproductive Medicine, Department of Gynecological, Obstetrical, and Pediatric Sciences, University of Perugia, Perugia, Italy

Corresponding Author InformationReprint requests: Prof. Vittorio Unfer, A.G.UN.CO. Obstetrics and Gynecology Centre, Via G. Cassiani, 15-00155 Rome, Italy (FAX: 39-06-3241284).

PII: S0015-0282(04)00530-8

doi:10.1016/j.fertnstert.2003.11.041


View previous. 2 of 65 View next.